Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Nutex Health (NUTX) over the last 15 years, with Q3 2025 value amounting to $96.8 million.

  • Nutex Health's Net Income towards Common Stockholders rose 145099.79% to $96.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $228.0 million, marking a year-over-year increase of 80726.18%. This contributed to the annual value of $52.2 million for FY2024, which is 21396.16% up from last year.
  • Per Nutex Health's latest filing, its Net Income towards Common Stockholders stood at $96.8 million for Q3 2025, which was up 145099.79% from $16.1 million recorded in Q2 2025.
  • Nutex Health's 5-year Net Income towards Common Stockholders high stood at $100.0 million for Q4 2024, and its period low was -$422.5 million during Q3 2022.
  • Its 5-year average for Net Income towards Common Stockholders is -$8.8 million, with a median of $1.1 million in 2021.
  • The largest annual percentage gain for Nutex Health's Net Income towards Common Stockholders in the last 5 years was 1180439.36% (2021), contrasted with its biggest fall of 367226.58% (2021).
  • Nutex Health's Net Income towards Common Stockholders (Quarter) stood at $1.1 million in 2021, then surged by 764.2% to $9.9 million in 2022, then crashed by 379.08% to -$27.7 million in 2023, then skyrocketed by 461.03% to $100.0 million in 2024, then fell by 3.25% to $96.8 million in 2025.
  • Its Net Income towards Common Stockholders was $96.8 million in Q3 2025, compared to $16.1 million in Q2 2025 and $15.0 million in Q1 2025.